Does vitamin D help maintain immune tolerance and reduce allergic-type inflammation?

Vitamin D is a key steroid hormone that plays a crucial role in maintaining immune system homeostasis and preventing runaway inflammatory cascades.

Molecular and cellular mechanisms

• Treg induction: Active vitamin D (calcitriol) binds to the vitamin D receptor (VDR) on CD4⁺ T cells to directly upregulate the transcription of FOXP3, CTLA-4, and Helios.
• Tolerogenic signaling: Calcitriol suppresses dendritic cell maturation, downregulating costimulatory molecules (CD80/CD86) and upregulating PD-L1 and IL-10. These tolerogenic dendritic cells subsequently drive the expansion of FoxP3⁺ and IL-10-producing regulatory T cells (Tregs) to maintain peripheral tolerance.
• Allergic pathway suppression: Vitamin D limits Th2-mediated inflammation by stabilizing mast cells against IgE-mediated degranulation, suppressing Th2 cytokines (IL-4, IL-5, IL-13), and reducing systemic IgE and eosinophil activation.

Clinical evidence

• Allergic rhinitis benefits: In clinical trials, adjuvant vitamin D supplementation significantly reduces Total Nasal Symptom Scores (TNSS), serum IgE, and blood eosinophil counts.
• Context-dependent efficacy: While vitamin D consistently increases circulating Treg frequencies, clinical benefits for broader atopic conditions like asthma show higher heterogeneity, with the most robust therapeutic effects observed in individuals correcting an underlying deficiency.

Bottom line

• Vitamin D acts as a powerful immunomodulator that supports immune tolerance and dampens allergic inflammation by directly promoting FoxP3⁺ Treg expansion and stabilizing mast cells, offering the greatest clinical benefit when used to correct deficiency.